Effective June 17, 2023, the board of directors of Lipella Pharmaceuticals Inc. appointed Dr. Lori Birder as a member of the Board. Dr. Birder will serve as a director until the next annual meeting of the Companyâs stockholders, at which time she will stand for election until the annual meeting of the Companyâs stockholders following her election, or her earlier resignation, retirement or other termination of service.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.725 USD | +1.97% | +0.69% | -28.92% |
Apr. 17 | Lipella Pharmaceuticals Inc. Appoints Jason Hafron and Pradeep Tyagi to Scientific Advisory Board | CI |
Apr. 09 | Maxim Initiates Lipella Pharmaceuticals at Buy Rating With $2 Price Target | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.92% | 5.1M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.78% | 22.18B | |
-16.67% | 21.2B | |
-8.79% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- LIPO Stock
- News Lipella Pharmaceuticals Inc.
- Lipella Pharmaceuticals Inc. Appoints Lori Birder as a Member of the Board